ALLOS THERAPEUTICS INC (ALTH) has 82 open-market insider trades by 20 insiders since 2005. The most active filer is Felix Baker, 10%.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Acquisition Sub Inc. Sapphire | 10% | — | 1 | $238.2M | 2012-09-05 |
| Julian Baker | 10% | — | 15 | $26.4M | 2008-02-25 |
| Pincus Private Equity Viii L. P. Warburg | Dir10% | — | 1 | $19.7M | 2008-05-29 |
| Stewart Hen | Dir | — | 1 | $19.7M | 2008-05-29 |
| Jonathan S. Leff | Dir | — | 1 | $19.7M | 2012-09-04 |
| Felix Baker | 10% | — | 16 | $17.4M | 2009-01-23 |
| Biotech Capital (gp) Llc Baker | 10% | — | 6 | $4.1M | 2008-05-22 |
| Capital (gp) Llc 14159 | 10% | — | 4 | $419K | 2008-05-22 |
| Brothers Life Sciences Capital (gp) Llc Baker | 10% | — | 1 | $207K | 2008-01-23 |
| Michael E. Hart | — | — | 1 | $155K | 2006-05-26 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Acquisition Sub Inc. Sapphire | 10% | Buy | $238.2M | 2012-09-05 |
| Michael E. Schick | VP & Sales and Marketing | Sell | $1K | 2012-07-11 |
| Bruce K. Bennett Jr. | VP & Pharmaceutical Operations | Buy | $1K | 2012-04-27 |
| Charles Q. Morris | Chief Medical Officer | Sell | $14K | 2012-04-27 |
| Charles Q. Morris | Chief Medical Officer | Sell | $15K | 2012-03-01 |
| Marc H. Graboyes | SVP & General Counsel | Sell |
Companies that share insiders with ALTH, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| $29K |
| 2012-02-29 |
| Bruce A. Goldsmith | SVP & Corporate Development | Sell | $14K | 2012-02-29 |
| Charles Q. Morris | Chief Medical Officer | Sell | $15K | 2012-02-29 |
| Bruce K. Bennett Jr. | VP & Pharmaceutical Operations | Sell | $9K | 2012-02-29 |
| Paul L. Berns | CEO | Sell | $64K | 2012-02-29 |
| David C. Clark | VP & Finance | Sell | $10K | 2012-02-29 |
| Michael E. Schick | VP & Sales and Marketing | Sell | $12K | 2012-02-29 |
| Bruce A. Goldsmith | SVP & Corporate Development | Sell | $5K | 2012-02-23 |
| David C. Clark | VP & Finance | Sell | $3K | 2012-02-23 |
| Paul L. Berns | CEO | Sell | $21K | 2012-02-23 |